Associations between patients' risk attitude and their adherence to statin treatment - A population based questionnaire and register study

BMC Family Practice

Volumn 17, Issue 1, 2016, Pages

  Barfoed, Benedicte Lind ^a   Paulsen, Maja Skov ^b   Christensen, Palle Mark ^c   Halvorsen, Peder Andreas ^d   Kjær, Trine ^a   Larsen, Mogens Lytken ^e   Larsen, Pia Veldt ^a,f   Nielsen, Jesper Bo ^a   Søndergaard, Jens ^a   Jarbøl, Dorte Ejg ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Danish Quality Unit of General Practice   (Denmark)

^c General Practitioners Lærkevej ^*  (Denmark)

^d UNIVERSITY OF TROMSØ   (Norway)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adherence; Cardiovascular; General practice; Risk attitude; Statins

Indexed keywords

ADULT; ATTENTION; COMORBIDITY; CONTROLLED STUDY; DANISH CITIZEN; DOCTOR PATIENT RELATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; QUESTIONNAIRE; SYMPTOM; AGED; COHORT ANALYSIS; DENMARK; FEMALE; GENERAL PRACTICE; HIGH RISK BEHAVIOR; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; COHORT STUDIES; DENMARK; FEMALE; GENERAL PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; REGISTRIES; RISK-TAKING; SURVEYS AND QUESTIONNAIRES;

EID: 84960388582     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-016-0423-1     Document Type: Article

References (41)

1. World Health Organisation. Adherence to long-term therapies: Evidence for action. 2003. http://www.who.int/chp/knowledge/publications/adherence-report/en/. (accessed 14 Jul 2015).
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
3. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
4. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535-44.
5. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331-42.
6. Hansen DG, Vach W, Rosholm J-U, Søndergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract. 2004;21:623-9.
7. Elliott RA, Marriott JL. Standardised assessment of patients' capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.
8. Nunes V, Neilson J, O'Flynn N, Calvert N, Kuntze S, Smithson H, et al. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. London: Royal College of General Practitioners; 2009.
9. Felde LK. The everyday elasticity of compliance in a symptomless disease. Commun Med. 2011;8:123-34.
10. Hoel Felde LK. 'I take a small amount of the real product': Elevated cholesterol and everyday medical reasoning in liminal space. Health (London). 2011;15:604-19.
11. Anderson LR, Mellor JM. Predicting health behaviors with an experimental measure of risk preference. J Health Econ. 2008;27:1260-74.
12. Barsky RB, Juster FT, Kimball MS, Shapiro MD. Preference parameters and behavioral heterogeneity: an experimental approach in the health and retirement study. Q J Econ. 1997;112:537-79.
13. Dave D, Saffer H. Alcohol demand and risk preference. J Econ Psychol. 2008;29:810-31.
14. Picone G, Sloan F, Taylor Jr D. Effects of risk and time preference and expected longevity on demand for medical tests. J Risk Uncertain. 2004;28:39-53.
15. Harmsen CG, Kristiansen IS, Larsen PV, Nexoe J, Stovring H, Gyrd-Hansen D, et al. Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. Br J Gen Pract. 2014;64:e199-207.
16. Gray GM, Ropeik DP. Dealing with the dangers of fear: the role of risk communication. Health Aff (Millwood). 2002;21:106-16.
17. John von N, Morgenstern O. Theory of Games and Economic Behavior (60th Anniversary Commemorative Ed). Princeton, NJ, USA: Princeton University Press; 2007.
18. Jackson DN, Hourany L, Vidmar NJ. A four-dimensional interpretation of risk taking. J Pers. 1972;40:483-501.
19. Weber EU, Blais AR, Betz NE. A domain-specific risk-attitude scale: Measuring risk perceptions and risk behaviors. J Behav Decis Mak. 2002;15:263-90.
20. Rasmussen S, Sondergaard J, Larsen PV, Balasubramaniam K, Elnegaard S, Svendsen RP, et al. The Danish symptom cohort: questionnaire and feasibility in the nationwide study on symptom experience and healthcare-seeking among 100 000 Individuals. Int J Family Med. 2014. doi: 10.1155/2014/187280.
21. Elnegaard S, Andersen RS, Pedersen AF, Larsen PV, Sondergaard J, Rasmussen S, et al. Self-reported symptoms and healthcare seeking in the general population -Exploring "The Symptom Iceberg". BMC Public Health. 2015;15:685.
22. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis. Med Decis Making. 2002;22:506-13.
23. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39 Suppl 1:38-41.
24. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39 Suppl 7:30-3.
25. Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39 Suppl 7:103-5.
26. Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39 Suppl 7:91-4.
27. Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39 Suppl 7:95-8.
28. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279:1458-62.
29. Larsen J, Andersen M, Kragstrup J, Gram LF. High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol. 2002;53:375-8.
30. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25:2303-10.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
32. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-61.
33. Varian HR. Intermediate microeconomics: a modern approach. 8th ed. New York: W.W. Norton & Co.; 2010.
34. Rasmussen JN, Rasmussen S, Gislason GH, Abildstrom SZ, Schramm TK, Torp-Pedersen C, et al. Persistent socio-economic differences in revascularization after acute myocardial infarction despite a universal health care system-a Danish study. Cardiovasc Drugs Ther. 2007;21:449-57.
35. Paulsen MS, Andersen M, Munck AP, Larsen PV, Hansen DG, Jacobsen IA, et al. Socio-economic status influences blood pressure control despite equal access to care. Fam Pract. 2012;29:503-10.
36. King KM, Norris CM, Knudtson ML, Ghali WA. Risk-taking attitudes and their association with process and outcomes of cardiac care: a cohort study. BMC Cardiovasc Disord. 2009;9:36.
37. Nightingale SD. Risk preference and laboratory test selection. J Gen Intern Med. 1987;2:25-8.
38. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-9.
39. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691-705.
40. Franklin JM, Shrank WH, Pakes J, Sanfelix-Gimeno G, Matlin OS, Brennan TA, et al. Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care. 2013;51:789-96.
41. Rolison JJ, Hanoch Y, Wood S, Liu PJ. Risk-Taking Differences Across the Adult Life Span: A Question of Age and Domain. J Gerontol B Psychol Sci Soc Sci. 2013;69:870-80.